Clinical trial
Evaluation of Efficacy and Safety Using oXiris Versus M100 Filter in Pneumonia-induced Acute Kidney Injury (AKI) Patients Requiring Continuous Renal Replacement Therapy (CRRT)
NCT06440759 is registered in ClinicalTrials.gov with Mohd Zulfakar Mazlan, MBBS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Efficacy and Safety Using oXiris Versus M100 Filter in Pneumonia-induced Acute Kidney Injury (AKI) Patients Requiring Continuous Renal Replacement Therapy (CRRT)
- Lead sponsor
- Mohd Zulfakar Mazlan, MBBS
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 30, 2024
- Completion date
- May 1, 2026
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aki - acute kidney injury, pneumonia